Rarity Bioscience in a a €6.5 million funding round led by Navigare Ventures, joined by existing shareholders Novalis Biotech and UU Invest
09 June 2024
09 June 2024
Total investments received (USD): 10.08M
Round value (USD): 7M
Company: Rarity Bioscience
Industry: BiotechHealth services
Related deals
Gradientech raises SEK 49.2 million
Investments
14 March 2026
Sigrid Therapeutics raised $5 million
Investments
30 December 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom